Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia.
Journal: Neoplasia (New York, N.Y.)
Published: September 26, 2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.
Journal: Cancer immunology, immunotherapy : CII
Published: May 03, 2017
Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector/memory CD8 T cells in a poorly immunogenic tumor model.
Journal: Cancer immunology research
Published: November 13, 2014
Slitrk5 Mediates BDNF-Dependent TrkB Receptor Trafficking and Signaling.
Journal: Developmental cell
Published: October 30, 2014
PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.
Journal: Journal for immunotherapy of cancer
Published: January 01, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026